The CIC and Drug Science have written to new Drugs Minister Dame Diana Johnson MP, calling for a liberalisation of the regulations around research. We are calling on the Government to back a number of recommendations they have received from the Advisory Council on the Misuse of Drugs (ACMD). Implementing these recommendations will reduce licencing […]
Read More
The CIC is pleased to welcome Luke Strong as our newest Student Ambassador. Luke is currently a second-year philosophy student at Queen’s University Belfast. He eagerly wants to aid in the pursuit of ethically realising the medicinal potential of cannabis and psychedelics. Luke aspires to contribute to these industries from a policy perspective, advocating for […]
Read More
The Care Quality Commission (CQC) has recently released a report called ‘The safer management of controlled drugs: annual update 2023‘. In a section entitled ‘Administration of CBPMs in health and social care settings’, the CQC have advised that providers (e.g. clinics, pharmacies) should consider the following in their policies and processes: ensuring the product has […]
Read More
A new report from the Care Quality Commission has found an increase in CBPM prescriptions of 118 per cent from 2021/22 to 2022/23. Specifically, the numbers released were as follows: 1 July 2021 to 30 June 2022: 81,476 items dispensed. 1 July 2022 to 30 June 2023: 177,566 items dispensed. This data relates specifically to […]
Read More
Following the announcement of the Government’s legislative agenda in the Kings Speech this week, Cannabis Industry Council Co-Chairs Jamie Bartley and Dr Callie Seaman commented: “The Government has said that economic growth is a top priority for their period in office. Cannabis has the potential to grow the UK economy by billions of pounds and […]
Read More
CIC has launched a new Rare Diseases Working Group, which aims to: Raise awareness in the use of pharmaceutical cannabinoids in rare diseases (engagement with rare disease charities etc…) Help create robust innovative clinical trials for pharmaceutical cannabinoids through life sciences Look to how we can incentivise industry to invest in rare disease research and […]
Read More
Following Labour’s general election win on 4 July, new ministerial appointments have been made across Government. Notable positions for the cannabis industry include: Prime Minister – Rt Hon Sir Keir Starmer MP Chancellor – Rt Hon Rachel Reeves MP Home Secretary – Rt Hon Yvette Cooper MP Health Secretary – Rt Hon Wes Streeting MP […]
Read More
With the UK General Election set for Thursday 4 July, the main political parties are now releasing their manifestos. Below is a summary of their manifesto policies with direct and indirect links to cannabis (all text copied direct from the manifestos): Labour (manifesto here) As part of Labour’s life sciences plan, we will develop an […]
Read More
A manifesto for change in the cannabis space has been published by the Cannabis Industry Council (CIC), the voice of the UK sector. The manifesto contains a number of policy proposals for the Government, which will improve patient access to medicines, increase foreign direct investment to the industry, and boost revenues for farmers. The specific […]
Read More
Medical cannabis prescription patient numbers could reach 62,960 by the end of this year, according to new analysis from CIC member Prohibition Partners. The figure includes anyone who received at least one prescription for medical cannabis during 2024. Prohibition Partners say the average patient spends £3,261 on their cannabis medication per year. A previous estimate […]
Read More